Institute pipeline

Innovation pipelines

Our institute has a wide range of technologies, capabilities and services available to industry.

Vaccines

	Antigen discovery	Vaccine prototype	Preclinical studies	Phase 1 trials	Available/ Partnered
Group A Streptococcus (peptide conjugate)	x	x	x	x	A
Group A Streptococcus (liposomal formulation)	x	x	x		P
Malaria (attenuated whole parasite blood stage)	x	x	x	x	A
Gonorrhoea (5 antigens)	x	x	x		A
Chikungunya virus (attenuated virus)	x	x	n		A
Zika virus (attenuated virus)	x	x	x		P
HIV (virus-like particle)	x	x			A
Middle ear infection	x	x			A
Babesiosis	x	x			A
Meningitis	x				A

	Target Discovery	Hits / Leads	Preclinical studies	Phase 1 trials	Phase 2 trials	Available/ Partnered
Ross River virus (small molecule)	x	x	x	x		P
Croup/Human Parainfluenza Virus 1 & 3 (small molecule)	x	x				A
Influenza (small molecule)	x	x				A
Hand, foot and mouth disease (small molecule)	x	x				A
Sepsis (small molecule)	x	x	x	x	x	P
Anticancer agent (peptide inhibitor)	x	x				A
Antibacterial agent (peptide inhibitor)	x	x				A
Streptococcal Toxic Shock Syndrome (mAbs therapeutic)	x	x	x			A
Gonorrhoea (small molecule)	x	x	x	x		A
Wound healing agents (small molecule)	x	x				A
Triple-negative breast cancer	x					A
Head and neck cancer	x					A
Ovarian cancer	x					A
Leukaemia (small molecule)	x	x				A
Melanoma	x					A
Prostate cancer	x					A
Stomach cancer	x					A
Respiratory Syncytial Virus (RSV)						A
Food-borne allergens	x	x				A
HIV	x					A
Tuberculosis (small molecule)	x	x				A
Gastroenteritis (antibiotic)	x	x				A

	Type	Stage	Available/ Partnered
Cancer diagnostic (biomarker)	Diagnostic	Prototype	A
Glycan Array (platform product)	Service	On market	N/A
Prebiotics and nutritional products	Technology	Discovery	A
Sulfation method	Method	On market	A
Prebiotics and nutritional products	Service	On market	N/A

Contact the Business Development team